Company news
MannKind Corporation news in 2019
MannKind Corporation's news releases, calls and decks from 2019, newest first.
Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza® Relative to Insulin Aspart in Type 1 Diabetes
December 19, 2019
MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 28, 2019
MannKind Appoints Tony Hooper to Its Board of Directors
November 20, 2019
MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results
November 5, 2019
MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics
November 3, 2019
MannKind Corporation to Hold 2019 Third Quarter Financial Results Conference Call on November 6, 2019
October 29, 2019
MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference
September 25, 2019
MannKind Presents Positive Afrezza® Clinical Data from Type 1 Diabetes Study at 55th Annual Meeting of the EASD
September 18, 2019